Vimarsana
Biggest News Aggregation in the World

Page 3 - Data Manipulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data Manipulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Manipulation Today - Breaking & Trending Today

Harvard cancer centre retracts 6 studies, correct 31 others over fraud claims - Vimarsana News

Harvard cancer centre retracts 6 studies, correct 31 others over fraud claims

A cancer centre and research institute affiliated to Harvard University had to retract six studies and correct 31 others as part of ongoing investigations into fraud allegations.

Harvard cancer institute to retract 6 studies, correct 31 others - Vimarsana News

Harvard cancer institute to retract 6 studies, correct 31 others

The Dana-Farber Cancer Institute, a Harvard teaching school, is moving to retract six studies and correct 31 others following allegations of data manipulation.

Source: nbc-2.com
Harvard cancer institute to retract 6 studies, correct 31 others - Vimarsana News

Harvard cancer institute to retract 6 studies, correct 31 others

The Dana-Farber Cancer Institute, a Harvard teaching school, is moving to retract six studies and correct 31 others following allegations of data manipulation.

Source: wdsu.com
Corporate leaders risk failure if their own data dashboards start lying to them - Vimarsana News

Corporate leaders risk failure if their own data dashboards start lying to them

Losing touch with reality is easy when a business culture allows its information feed to be fudged. Alas, it happens much too often.

CDSCO uncovers data manipulation, SOP violations by public testing labs - Vimarsana News

CDSCO uncovers data manipulation, SOP violations by public testing labs

The Central Drugs Standard Control Organisation (CDSCO), along with state drug inspectors, have been doing these inspections as part of a massive nationwide crackdown on spurious and substandard medicines. At present Phase IV of risk based inspections (RBI) is ongoing.